Cell-permeable peptide inhibitors of the JNK signal transduction pathway

Details for Australian Patent Application No. 2006291541 (hide)

Owner Xigen S.A.

Inventors Bonny, Christophe

Agent Cullens

Pub. Number AU-B-2006291541

PCT Pub. Number WO2007/031280

Priority PCT/ EP2005/009782 12.09.05 EP

Filing date 12 September 2006

Wipo publication date 22 March 2007

Acceptance publication date 12 April 2012

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/031280 Priority application(s): WO2007/031280

12 April 2012 Application Accepted

  Published as AU-B-2006291541

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006291545-Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics

2006291528-Body for a motor vehicle